Rituximab therapy for Morvan syndrome associated with myasthenia gravis.
Michael
M
Weiss
D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab; D013595:Syringomyelia / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab